2004
DOI: 10.1007/s00431-004-1460-7
|View full text |Cite
|
Sign up to set email alerts
|

Smith-Magenis syndrome and growth hormone deficiency

Abstract: we suggest that an investigation of both growth hormone secretion and function is carried out in patients with Smith-Magenis syndrome and 17p11.2 deletion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2005
2005
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…One suspects that there must be many more syndromes [5,11] . The Smith-Magenis syndrome (SMS; OMIM # 182290) [11] is notable for the presence of short stature, mental retardation, as well as brachycephaly and broad nose, as in our propositus [3,15,16] . However, the behavioural problems in SMS which include severe self-injurious behaviour and polyembolokoilamania (placing foreign objects into body orifi ces) that dominate the clinical picture in SMS, are not present in our patient.…”
Section: Discussionmentioning
confidence: 99%
“…One suspects that there must be many more syndromes [5,11] . The Smith-Magenis syndrome (SMS; OMIM # 182290) [11] is notable for the presence of short stature, mental retardation, as well as brachycephaly and broad nose, as in our propositus [3,15,16] . However, the behavioural problems in SMS which include severe self-injurious behaviour and polyembolokoilamania (placing foreign objects into body orifi ces) that dominate the clinical picture in SMS, are not present in our patient.…”
Section: Discussionmentioning
confidence: 99%
“…The total secretion of GH has been proved to be normal, although the peak values were lower than those of controls [ 30 ]. On the other hand, a GH deficit was identified three times [ 25 , 31 , 32 ] and replacement therapy might have proved to be effective for the final stature only once [ 32 ], requiring further studies to elucidate its real benefit. Microcephaly is not common and varies from 16% [ 25 ] to 37.5% [ 33 ].…”
Section: Clinical Featuresmentioning
confidence: 99%